Use of tDCS Applied to the Orbitofrontal Cortex to Improve Risky Decision-making in a Clinical Population

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
Mood DisordersDepressionSuicide
Interventions
DEVICE

Active transcranial direct current stimulation (tDCS)

"Description of the tDCS session:~* Placement of conductive electrodes, attached to the scalp. The electrodes are placed in individual sponge cases moistened with a saline solution. A sponge towel is placed on the patient's shoulders to prevent any clothing from becoming damp. The electrodes are held in place by a dedicated net.~* The anode is placed in the left supraorbital region (site Fp1 EEG 10/20 system). The cathode was placed in the right supraorbital region (site Fp2 EEG 10/20 system).~* Patients received 1.5 mA stimulation for 30 minutes."

DEVICE

Sham transcranial direct current stimulation (tDCS)

"Description of the tDCS session:~* Placement of conductive electrodes, attached to the scalp. The electrodes are placed in individual sponge cases moistened with a saline solution. A sponge towel is placed on the patient's shoulders to prevent any clothing from becoming damp. The electrodes are held in place by a dedicated net.~* The anode is placed in the left supraorbital region (site Fp1 EEG 10/20 system). The cathode was placed in the right supraorbital region (site Fp2 EEG 10/20 system).~* Patients received effective stimulation of 1.5 mA for 30 seconds, after which the current was switched off. The entire session lasted 30 minutes, with 29 minutes and 30 seconds without stimulation."

Trial Locations (1)

75014

RECRUITING

GHU Paris Psychiatrie et Neurosciences - Hôpital Sainte-Anne - CMME, Paris

All Listed Sponsors
lead

Centre Hospitalier St Anne

OTHER